DNA is continuously exposed to chemical damage. Thousands of reactions occur inside every cell each day, and some of them alter DNA bases, break chemical bonds or interfere with the normal pairing of the two strands. Cells possess several repair systems that patrol the genome and correct many of these lesions. But repair is not perfect. Some damaged sites are recognized quickly and repaired efficiently, while others remain undetected long enough to be copied during cell division. Once a damaged base is converted into a different sequence through replication or faulty repair, the change may become permanent. “The rate at which mutations accumulate is a balance between the rate of damage and the rate of repair,” explains Dr. Ariel Afek, whose laboratory led the study. That balance is not uniform across the genome, and the new work helps reveal why.

Most research on genome instability has focused on mutations that are easy to observe because they remain as lasting changes in DNA. Afek’s team instead examined the temporary lesions that precede those changes. This distinction is important because a damaged DNA base does not inevitably become a mutation. Its fate depends on whether repair enzymes locate it, bind to it and remove it before the cell copies the damaged strand. To investigate these early steps, the researchers created a molecular chip containing thousands of short DNA molecules. Each molecule carried the same type of artificial damage, but the surrounding DNA letters were varied. This design allowed the scientists to compare repair activity at many sequence contexts while keeping the central lesion constant.

The experiments showed that the repair enzymes did not treat every damaged site equally. Their ability to recognize and bind the lesion depended on the precise combination of bases around it. The influence extended as far as five DNA positions upstream or downstream from the damaged base, indicating that the enzymes read a much larger molecular environment than the lesion alone. Noga Levy, a doctoral student in Afek’s laboratory and the study’s lead researcher, compared this behavior to an editor evaluating a word in context rather than in isolation. A damaged base may be chemically identical in two locations, yet the surrounding sequence can determine whether a repair protein notices it efficiently or passes it by.

The sequence effect was not simply a matter of the letters themselves. The researchers found that preferred DNA sequences shared physical characteristics, including distinctive shapes in the double helix. DNA is often represented as a uniform spiral staircase, but its structure changes subtly from one sequence to another. Some combinations of bases bend more easily, widen or narrow the grooves on the helix, or alter the distribution of electrical charge along the molecule. One of the repair enzymes studied by the team favored damaged sites embedded in sequences that create an unusually narrow region of the double helix. Such structural variation can provide a recognition signal that complements the chemical features of the damaged base.

To understand the molecular basis of this preference, the Weizmann researchers collaborated with a group led by Prof. Brian P. Weiser at Rowan University in New Jersey. Using computer simulations, the scientists examined how the repair enzyme moved across DNA and interacted with the region surrounding the lesion. The simulations indicated that one amino acid in the enzyme scans the local DNA structure. It is attracted to the negative electrical charge associated with the narrow helical region, helping guide the protein toward sequences with the appropriate shape. This model illustrates how DNA repair can depend on both chemistry and mechanics: the enzyme is not only searching for a damaged base, but also sensing the architecture and electrostatic landscape of the surrounding double helix.

The team then asked whether these biochemical preferences could be detected in the human genome after millions of years of evolution. One common form of genomic damage occurs when a cytosine, or C base, is chemically altered and no longer pairs correctly with guanine. Several important repair enzymes identify and remove the incorrect base, restoring the proper sequence. The researchers reasoned that genomic regions where a particular repair enzyme operates efficiently should preserve more cytosines, because damage at those sites would be more likely to be corrected. In regions where repair is inefficient, comparable damage should more often escape correction and accumulate as mutations. Analysis of genomic data revealed a correlation consistent with this prediction for one of the enzymes. The result suggests that repair preferences are not merely laboratory curiosities; over evolutionary time, they can influence which sequences remain stable and which become progressively altered.

That observation has implications for interpreting human evolution. When scientists identify genetic changes that became common in modern humans, they often ask whether those changes were favored because they helped people adapt to environmental pressures. But not every widespread change necessarily reflects natural selection. Some may have accumulated because the DNA sequence was especially vulnerable to damage or because repair enzymes were less effective in that context. “To identify which genomic changes were adopted by humans to survive a changing environment, we must first understand which changes accumulate naturally due to the preferences of the repair mechanisms,” Afek says. Distinguishing selection from repair-driven mutation could make evolutionary analyses more precise, particularly in genomic regions with unusually high or low mutation rates.

The same principle may help explain the genetic history of cancer. A tumor typically begins when one cell accumulates mutations that alter growth control, DNA maintenance or communication with neighboring cells. As that cell divides, additional changes form characteristic combinations known as mutational signatures. These signatures can reveal the kinds of damage that occurred and the repair pathways that were active or defective. In the new study, the researchers found a relationship between the sequence preferences of the repair enzymes and mutation patterns observed in human tumors. One explanation is that damage to repair systems in cancer cells allows mutations to accumulate in genomic regions that were previously protected. Another is that evolution has tuned repair enzymes to recognize regions that are intrinsically more vulnerable. Although the study does not establish a single cause, it reinforces the idea that repair activity is a major force shaping cancer genomes.

The findings may ultimately have practical applications beyond understanding mutation. DNA repair enzymes are already used in biotechnology and gene-editing systems, where their ability to recognize particular structures can be harnessed to modify genetic material. Mapping the sequence and shape preferences of these proteins could allow researchers to design more precise molecular tools or engineer enzymes that protect vulnerable regions of the genome more effectively. Afek’s laboratory is extending the approach to additional repair mechanisms in work led by graduate student Noga Carmon. By studying repair as a process that combines damage recognition, sequence context, molecular shape and electrical charge, scientists may gain a more complete view of how cells preserve genetic information—and how failures in that preservation can drive disease.

Web References: Nature Communications article; DOI link

References: Nature Communications, DOI: 10.1038/s41467-026-74090-0

Keywords: DNA repair, mutations, genome stability, genetic damage, structural biology, DNA sequence context, cancer genomics, mutational signatures, evolution, gene editing

At the heart of this research lies the question of how DNA damage influences stem cell behavior over the long term and how these responses affect the delicate balance between aging phenotypes and tumorigenesis. DNA damage, whether from environmental radiation, chemical insults, or internal metabolic byproducts, accumulates in cells and is closely tied to aging and cancer risk. However, the exact molecular mechanisms that dictate how stem cells specifically respond to diverse genotoxic stresses have remained elusive until now.

Utilizing sophisticated in vivo lineage tracing models coupled with comprehensive gene expression profiling in murine systems, the research team uncovered a novel process termed senescence-coupled differentiation or “seno-differentiation.” This cellular program is triggered by DNA double-strand breaks typical of cytotoxic genotoxins such as X-ray irradiation. Through activation of the p53–p21 stress-response axis, McSCs are driven into irreversible differentiation and exit the stem cell pool, a response that ultimately depletes the melanocyte progenitor pool. Clinically, this manifests as hair greying, a hallmark of aging and tissue exhaustion.

Intriguingly, the researchers discovered a starkly contrasting fate when McSCs encountered carcinogenic genotoxins, such as 7,12-dimethylbenz(a)anthracene or ultraviolet B radiation. In these contexts, McSCs evade the protective seno-differentiation pathway and maintain self-renewal capacity, clonally expanding despite carrying DNA damage. This survival and proliferative advantage depend on signals from the local microenvironment, especially the KIT ligand secreted by epidermal niche cells. The KIT signaling pathway effectively suppresses the differentiation program, enabling damaged stem cells to persist and expand, which sets the stage for melanoma initiation and progression.

This dualistic model of stem cell fate under genotoxic stress challenges conventional wisdom and suggests a unified framework through which aging and cancer are linked via stem cell biology. Rather than viewing hair greying and melanoma as distinct, unrelated phenomena, this study reveals them as divergent biological outcomes rooted in how stem cells integrate intrinsic DNA damage signals with extrinsic niche cues.

The practical implications of this research are profound. Senescence-coupled differentiation acts as a natural “senolytic” mechanism, selectively eliminating genomically unstable cells and thereby serving a protective function to prevent malignant transformation. However, when this safeguard is bypassed due to altered microenvironmental signaling, damaged stem cells are allowed to escape differentiation and contribute to cancer formation. Understanding these pathways opens new possibilities for therapeutic intervention, potentially enabling the manipulation of stem cell fates to favor tissue maintenance while reducing cancer risk.

At the molecular level, the involvement of the p53–p21 tumor suppressor pathway underscores the critical role of canonical DNA damage responses in directing stem cell fate decisions. The molecular crosstalk between genotoxic stress sensors and differentiation programs appears finely tuned to preserve tissue homeostasis but is also vulnerable to disruption by carcinogens modifying the local signaling landscape.

Further highlighting the complexity, the metabolic reprogramming observed—particularly alterations in arachidonic acid metabolism—in response to carcinogenic stress, points to an interplay between metabolic states and stem cell function that may govern susceptibility to tumorigenesis. This metabolic axis offers yet another layer of regulation linking environmental factors, cell signaling, and fate determination.

In addition to state-of-the-art experimental approaches, this study benefits from a multidisciplinary perspective integrating stem cell biology, dermatology, cancer research, and molecular genetics. The collaborative effort, encompassing expertise from institutes including RIKEN and Yamagata University alongside The University of Tokyo, reflects the necessity of combining broad scientific disciplines to unravel the intricacies of stem cell stress responses.

Importantly, the research explicitly clarifies that hair greying is not protective per se but represents a visible marker of an underlying protective cellular mechanism—seno-differentiation—that curtails the accumulation of potentially oncogenic cells. Thus, the conventional association between hair graying and biological aging gains an additional dimension as a readout of tissue-level DNA damage management.

Looking forward, these insights pave the way for novel strategies aimed at modulating microenvironmental factors such as KIT signaling to influence stem cell fate decisions. Pharmacological targeting of these pathways might one day suppress melanoma initiation or slow hair follicle aging, representing a dual benefit in combating cancer and age-associated tissue decline.

Professor Emi Nishimura, renowned for her pioneering work discovering melanocyte stem cells and elucidating their role in pigmentation and aging, underscores that the ability of the same stem cell population to adopt antagonistic fates—exhaustion versus expansion—reflects an evolutionary balancing act between tissue renewal and cancer prevention. This conceptual framework provides a blueprint for future research exploring stress response mechanisms not only in skin but potentially across other stem cell types and tissues.

Collectively, this landmark study offers a paradigm shift by linking molecular, cellular, and environmental factors in governing how stem cells decide between protective senescence-driven differentiation and pathological clonal expansion. Its findings herald a new era in understanding the biological interplay that shapes aging phenotypes and cancer risk, with profound implications for the development of precision medicine approaches targeting stem cell resilience and surveillance.

Subject of Research: Animals

Article Title: Antagonistic Stem Cell Fates Under Stress Govern Decisions Between Hair Greying and Melanoma

News Publication Date: 6-Oct-2025

Web References: https://doi.org/10.1038/s41556-025-01769-9

References: Mohri Y, Nie J, Morinaga H, et al. Antagonistic Stem Cell Fates Under Stress Govern Decisions Between Hair Greying and Melanoma. Nature Cell Biology. 2025 Oct 6. doi:10.1038/s41556-025-01769-9.

Image Credits: Emi K. Nishimura, The University of Tokyo

Keywords: Cancer, Biomedical engineering, Diseases and disorders, Health and medicine, Hair, Integumentary system, Tumorigenesis